ESCAPE | Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multi-morbid elderly patients

Summary
ESCAPE will rethink current practice for treating multimorbidity in elderly patients and break down health care silos that impede integrated care and lead to adverse outcomes. We will coordinate and optimise care, prioritising integration of treatment for mental distress and disorders in the treatment of multimorbidity. Our interdisciplinary multinational consortium of experts from general and hospital medical practice and psychology, health economics, ICT development and social innovation as well as patient and informal carer representatives, will develop a holistic, patient-centred intervention based on the blended collaborative care (BCC) approach and enhanced by cutting-edge information and communication technologies. Trained Care Managers will work closely together with the patient’s general practitioner under supervision of a Clinical Specialist Team. They will use a meta-algorithm integrated in the interactive imergo® e-health Integrated Care Platform to customise patients’ treatment to their individual needs and preferences and liaise among providers. The platform will also empower patients and informal carers to increase their intrinsic capacities. ESCAPE as a social innovation will decrease disease burden for patients, informal carers and ultimately society and improve their quality of life (QoL), prioritised as the most important treatment outcome by patients, carers, and multimorbidity guidelines. ESCAPE will conduct for the first time a randomised controlled trial embedded in a comprehensive cohort study design to compare BCC and usual care. We will include patients with heart failure, ≥2 medical comorbidities and psychological distress. The primary effectiveness endpoint will be patients’ health-related QoL. Medical outcomes, cost-effectiveness, and several other patient-relevant outcomes will be secondary endpoints. We will apply an active dissemination and exploitation strategy to derive maximum impact from the new pathway for multimorbidity care.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/945377
Start date: 01-04-2021
End date: 30-09-2025
Total budget - Public funding: 6 101 206,00 Euro - 6 101 206,00 Euro
Cordis data

Original description

ESCAPE will rethink current practice for treating multimorbidity in elderly patients and break down health care silos that impede integrated care and lead to adverse outcomes. We will coordinate and optimise care, prioritising integration of treatment for mental distress and disorders in the treatment of multimorbidity. Our interdisciplinary multinational consortium of experts from general and hospital medical practice and psychology, health economics, ICT development and social innovation as well as patient and informal carer representatives, will develop a holistic, patient-centred intervention based on the blended collaborative care (BCC) approach and enhanced by cutting-edge information and communication technologies. Trained Care Managers will work closely together with the patient’s general practitioner under supervision of a Clinical Specialist Team. They will use a meta-algorithm integrated in the interactive imergo® e-health Integrated Care Platform to customise patients’ treatment to their individual needs and preferences and liaise among providers. The platform will also empower patients and informal carers to increase their intrinsic capacities. ESCAPE as a social innovation will decrease disease burden for patients, informal carers and ultimately society and improve their quality of life (QoL), prioritised as the most important treatment outcome by patients, carers, and multimorbidity guidelines. ESCAPE will conduct for the first time a randomised controlled trial embedded in a comprehensive cohort study design to compare BCC and usual care. We will include patients with heart failure, ≥2 medical comorbidities and psychological distress. The primary effectiveness endpoint will be patients’ health-related QoL. Medical outcomes, cost-effectiveness, and several other patient-relevant outcomes will be secondary endpoints. We will apply an active dissemination and exploitation strategy to derive maximum impact from the new pathway for multimorbidity care.

Status

SIGNED

Call topic

SC1-BHC-24-2020

Update Date

26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.0. Cross-cutting call topics
H2020-SC1-2020-Two-Stage-RTD
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient